IRIS
RACANELLI, Vito
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.275
AS - Asia 5.814
EU - Europa 5.804
SA - Sud America 1.445
AF - Africa 272
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.051
SG - Singapore 2.434
RU - Federazione Russa 1.948
CN - Cina 1.380
BR - Brasile 1.157
SE - Svezia 900
IT - Italia 751
HK - Hong Kong 714
DE - Germania 547
FR - Francia 396
VN - Vietnam 363
FI - Finlandia 330
GB - Regno Unito 315
UA - Ucraina 252
IN - India 202
BD - Bangladesh 111
CA - Canada 108
ID - Indonesia 96
AR - Argentina 91
TR - Turchia 74
IQ - Iraq 67
ZA - Sudafrica 67
JP - Giappone 66
PL - Polonia 66
MX - Messico 65
BE - Belgio 61
CI - Costa d'Avorio 56
PK - Pakistan 50
CO - Colombia 48
VE - Venezuela 44
ES - Italia 43
NL - Olanda 41
MA - Marocco 40
EC - Ecuador 39
SA - Arabia Saudita 37
IE - Irlanda 34
UZ - Uzbekistan 34
CZ - Repubblica Ceca 30
AT - Austria 27
TN - Tunisia 24
KE - Kenya 22
PH - Filippine 22
CL - Cile 20
LT - Lituania 18
JO - Giordania 17
MY - Malesia 17
AE - Emirati Arabi Uniti 16
EG - Egitto 14
ET - Etiopia 14
NP - Nepal 14
JM - Giamaica 13
PY - Paraguay 13
BO - Bolivia 10
IR - Iran 10
LB - Libano 10
PE - Perù 10
IL - Israele 8
TH - Thailandia 8
OM - Oman 7
PS - Palestinian Territory 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
BH - Bahrain 6
DZ - Algeria 6
RS - Serbia 6
UY - Uruguay 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
RO - Romania 5
SR - Suriname 5
TT - Trinidad e Tobago 5
AO - Angola 4
CH - Svizzera 4
EU - Europa 4
GT - Guatemala 4
KR - Corea 4
KZ - Kazakistan 4
NG - Nigeria 4
PA - Panama 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TG - Togo 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
HN - Honduras 2
HT - Haiti 2
HU - Ungheria 2
KH - Cambogia 2
Totale 27.587
Salva come PNG Salva come JPEG
Città #
Ashburn 1.569
Singapore 1.347
Fairfield 1.283
Chandler 1.245
Woodbridge 1.120
San Jose 772
Nyköping 715
Hong Kong 710
Houston 623
Jacksonville 587
Ann Arbor 523
Seattle 523
Cambridge 516
Wilmington 476
Beijing 466
New York 407
Bari 257
Lawrence 233
Roxbury 231
Lauterbourg 219
Los Angeles 218
Nanjing 194
Dallas 172
Des Moines 152
Helsinki 152
Brooklyn 128
Munich 123
Ho Chi Minh City 120
Council Bluffs 118
Inglewood 110
São Paulo 107
Boardman 95
Princeton 92
Santa Clara 87
Hanoi 80
Buffalo 75
San Diego 69
Jakarta 64
Orem 59
Brussels 58
London 57
Abidjan 56
Nanchang 55
Grafing 54
Moscow 51
Shenyang 51
Tokyo 49
Hebei 47
Paris 47
Washington 47
Frankfurt am Main 46
Johannesburg 46
Chicago 43
Warsaw 43
Marseille 42
Denver 41
Rio de Janeiro 41
Dearborn 39
Rome 39
Toronto 39
Chennai 36
Jiaxing 36
Montreal 35
Dublin 33
Manchester 32
Dong Ket 31
Falkenstein 31
Milan 31
Tashkent 31
Tianjin 30
Changsha 29
Redwood City 29
Belo Horizonte 28
Pune 28
Baghdad 27
San Francisco 27
Turku 26
Boston 25
Guangzhou 25
Columbus 24
Nuremberg 24
Phoenix 24
The Dalles 24
Amsterdam 23
Dhaka 23
Atlanta 22
Brno 22
Ankara 21
Brasília 20
Quito 20
Salvador 20
Basingstoke 19
Caracas 19
Stockholm 19
Mumbai 18
Shanghai 18
Nairobi 17
New Delhi 17
Poplar 17
Bogotá 16
Totale 18.025
Salva come PNG Salva come JPEG
Nome #
HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia 774
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 755
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 292
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 243
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 220
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 216
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 209
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 203
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 194
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 191
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 190
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 188
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 185
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 184
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 182
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 181
A spatial view of the CD8(+) T-cell response: the case of HCV 180
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 180
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 178
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 174
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 173
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 171
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 170
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 170
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 168
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 168
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 167
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 167
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 166
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 161
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 159
Autoantibodies to intracellular antigens: generation and pathogenetic role 159
Goodpasture's disease: a report of ten cases and a review of the literature. 156
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 155
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 155
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 154
Age-related differences in human palatine tonsillar B cell subsets and immunoglobulin isotypes 153
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques 153
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 151
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 151
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 151
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 150
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 149
Bortezomib treatment modulates autophagy in multiple myeloma 148
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 147
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 147
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 146
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 146
The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review 145
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 144
Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity 143
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 142
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 139
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 138
Flogosis and heart involvement in large vessel vasculitis 137
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 136
Rheumatic disorders as paraneoplastic syndromes 135
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 134
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 133
Common variable immunodeficiency and gastric malignancies 132
B cell activation: general to HCV-specific considerations 131
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 131
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 131
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 130
Cross-priming of hepatitis C virus specific CD8+ T cells in mice by immunization with self-replicating RNA transfected dendritic cells 129
T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies 129
In vitro proliferation of naive B cells and memory B cells: different profiles from healthy and HCV-infected individuals 129
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 129
Cancer treatment and the KIR–HLA system: an overview 129
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 129
Actors on the scene: Immune cells in the myeloma niche 129
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 128
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 128
Clonal CD27+ CD19+ B-cell expansion through inhibition of FCgIIR in HCV+ cryoglobulinemic patients 127
Cyclosporine-A plus steroids, versus steroids alone, in the 12-month treatment of systemic lupus erythematosus 126
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers 126
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma 125
Bone marrow of persistently hepatitis C virus-infected individuals accumulates memory CD8+ T cells specific for current and historical viral antigens: A study in patients with benign hematological disorders 125
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 124
Extra-articular manifestations of rheumatoid arthritis: an update 124
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 123
Case series on amyloidosis and organ involvement: a single center experience 122
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 122
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 122
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 120
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 120
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 119
The liver as an immunological organ 119
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 119
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes 117
Carcinogenesis and Metastasis in Liver: Cell Physiological Basis 117
Hepatitis C virus infection: when silence is deception 116
Vasculitis in connective tissue diseases 116
Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome 115
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection 114
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. 113
Antibody production and in vitro behavior of CD27-defined B cell subsets: persistent HCV infection changes the rules 112
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 112
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules 112
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases 112
Totale 16.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 0 0 0 0 0 0 311 191 180
2021/20222.000 86 220 43 98 90 134 102 146 110 132 338 501
2022/20233.219 426 438 218 274 331 470 62 360 493 24 74 49
2023/20241.379 98 203 84 82 128 520 38 57 8 21 9 131
2024/20254.405 144 82 338 188 153 401 493 432 167 242 679 1.086
2025/20269.348 1.337 390 447 857 1.146 564 1.136 289 2.316 866 0 0
Totale 28.473